Hedera vs Injective Staking
Side-by-side comparison of HBAR and INJ staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Hedera vs Injective: which should you stake?
Injective currently offers the higher APY at 6.39% compared to Hedera's 2.26%. That's a 4.13 percentage point difference in annual yield.
In terms of market cap, Hedera is the larger asset at $3.83B, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Hedera vs Injective — common questions
Is Hedera or Injective better for staking?
Injective currently offers a higher staking APY at 6.39% compared to Hedera's 2.26%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Hedera and Injective?
Hedera offers 2.26% APY while Injective offers 6.39% APY — a difference of 4.13 percentage points.
Which is safer to stake: HBAR or INJ?
Hedera has a medium risk rating while Injective has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both HBAR and INJ?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Hedera and Injective spreads your risk across different networks and protocols.